Leadership

The Harvard Stem Cell Institute is led by faculty directors Douglas Melton and David Scadden, and executive director Brock Reeve. Together with the Executive Committee, HSCI leadership brings together deep expertise in science and business from across Harvard and its teaching hospitals. Their combined intellectual venture capital guides HSCI’s strategy in harnessing the power of stem cell science to improve patients’ lives.

Faculty Directors

 

Douglas A. Melton, Ph.D.

Xander University Professor of Stem Cell and Regenerative Biology, Harvard University

Investigator, Howard Hughes Medical Institute

 

David T. Scadden, M.D.

Gerald and Darlene Jordan Professor of Medicine, Harvard University

Professor of Stem Cell and Regenerative Biology, Harvard University

Director, Center for Regenerative Medicine, Massachusetts General Hospital

 

Executive Director

 

Brock Reeve, M.Phil, M.B.A.

 

Executive Committee

 

Leonard Zon, M.D., Chair

Professor of Stem Cell and Regenerative Biology, Harvard University

Grousbeck Professor of Pediatrics, Harvard Medical School

Director, Stem Cell Program, Boston Children’s Hospital

Investigator, Howard Hughes Medical Institute

 

Joseph V. Bonventre, M.D., Ph.D.

Chief, Division of Renal Medicine, Brigham and Women’s Hospital

Chief, Division of Engineering in Medicine, Brigham and Women’s Hospital

Samuel A. Levine Professor, Harvard Medical School

 

Susan Dymecki, M.D., Ph.D.

Professor of Genetics, Harvard Medical School

 

Albert Edge, Ph.D.

Director, Tillotson Cell Biology Unit and Principal Investigator, Eaton-Peabody Laboratories, Massachusetts Eye and Ear

Professor of Otolaryngology —Head and Neck Surgery, Harvard Medical School

 

Jenna Galloway, Ph.D.

Assistant Professor, Center for Regenerative Medicine and Department of Orthopedic Surgery, Massachusetts General Hospital

HSCI Musculoskeletal Program Leader

 

Carla F. Kim, Ph.D.

Professor of Genetics and Professor of Pediatrics, Harvard Medical School

Principal Investigator, Stem Cell Program, Boston Children’s Hospital

 

Jeffrey Macklis, M.D., D.Sc.Tech.

Max and Anne Wien Professor of Life Sciences, Harvard University

Professor of Stem Cell and Regenerative Biology, Harvard University

Professor of Neurology, Harvard Medical School

Faculty Member, Harvard University Center for Brain Science

 

Jerome Ritz, M.D.

Executive Director, Connell and O’Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute

Professor of Medicine, Harvard Medical School

 

Vicki Rosen, Ph.D.

Professor of Developmental Biology and Chair of the Department of Developmental Biology, Harvard School of Dental Medicine

HSCI Musculoskeletal Program Leader

 

Lee Rubin, Ph.D.

Professor of Stem Cell and Regenerative Biology, Harvard University

HSCI Nervous System Diseases Program Leader

 

Amy Wagers, Ph.D.

Forst Family Professor of Stem Cell and Regenerative Biology, Harvard University

Co-chair, Harvard Department of Stem Cell and Regenerative Biology

Senior Investigator, Joslin Diabetes Center

 

New faculty members 

 

In 2020, HSCI welcomed six new Principal Faculty members from schools and hospitals across our network.

 

Fei Chen, Ph.D.

Assistant Professor of Stem Cell and Regenerative Biology, Harvard University

Core Institute Member, Broad Institute of MIT and Harvard

 

Ryan Flynn, M.D., Ph.D.

Assistant Professor of Stem Cell and Regenerative Biology, Harvard University

Principal Investigator, Stem Cell Program, Boston Children’s Hospital

 

Ruth Franklin, Ph.D.

Assistant Professor of Stem Cell and Regenerative Biology, Harvard University

 

Leslie Kean, M.D., Ph.D.

Director, Stem Cell Transplant Center, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Robert A. Stranahan Professor of Pediatrics, Harvard Medical School

 

Kara McKinley, Ph.D.

Assistant Professor of Stem Cell and Regenerative Biology, Harvard University

 

Marc Wein, M.D., Ph.D.

Endocrine Unit, Massachusetts General Hospital

Assistant Professor of Medicine, Harvard Medical School